Stock Performance and Market Context
On 7 May 2026, Yatharth Hospital & Trauma Care Services Ltd’s stock closed at Rs 847.95, just 0.11% above its 52-week high of Rs 847.00. The stock outperformed the broader Sensex index, which recorded a marginal gain of 0.08% on the same day, while Yatharth Hospital surged 3.13%. This marks the continuation of a positive momentum, with the stock gaining 2.18% over the past two consecutive trading days and outperforming its hospital sector peers by 2.02% on the day.
The stock’s intraday high of Rs 840 represented a 2.16% increase, and it is currently trading above all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This technical positioning underscores a mildly bullish trend that has been in place since 10 April 2026, when the stock’s trend shifted from sideways to positive at a price level of Rs 755.20.
Long-Term Performance Comparison
Yatharth Hospital’s recent all-time high caps a period of strong relative performance. Over the past year, the stock has delivered an impressive 81.11% return, significantly outpacing the Sensex’s decline of 3.37%. Year-to-date, the stock has gained 24.41%, while the Sensex has fallen 8.45%. Over the last three months, the stock rose 31.94%, contrasting with the Sensex’s 6.65% decline. Even over the one-month period, the stock’s 25.55% gain dwarfs the Sensex’s 4.56% increase.
While the stock’s three-year, five-year, and ten-year returns are recorded as zero, this is likely due to data availability rather than performance, given the company’s classification as a small-cap entity and its recent market activity.
Valuation Metrics at Peak Price
At the current price of Rs 847.95, Yatharth Hospital trades at a price-to-earnings (P/E) ratio of 47 times trailing twelve months earnings, reflecting investor willingness to pay a premium for its earnings growth. The price-to-book value stands at 4.70 times, while enterprise value multiples include EV/EBITDA at 29.51 times and EV/EBIT at 40.50 times. The EV/Sales multiple is 7.05 times, and EV/Capital Employed is 5.34 times. The PEG ratio, which adjusts the P/E for growth, is 1.66 times, indicating a valuation that factors in the company’s growth prospects.
Dividend metrics are not applicable as the company has not declared dividends recently, with no dividend yield, payout, or ex-dividend date recorded.
Technical Analysis and Support Levels
The stock’s technical indicators present a mixed but generally positive picture. Weekly MACD is bullish, supported by bullish Bollinger Bands on both weekly and monthly timeframes. The Dow Theory also signals mild bullishness. However, some indicators such as monthly MACD and KST show mild bearishness, and moving averages on the weekly chart are mildly bearish, reflecting some caution in momentum.
Key support levels include the 52-week low at Rs 431.20, which is significantly distant from the current price, providing a strong base. Resistance levels to watch include the 20-day moving average at Rs 761.55, 100-day moving average at Rs 680.69, and 200-day moving average at Rs 711.22, all of which have been surpassed as the stock reached its new high.
Delivery Volumes and Market Activity
Recent delivery volumes indicate heightened investor participation. On 6 May 2026, delivery volume was 83,360 shares, accounting for 34.44% of total volume. This compares with a five-day average delivery volume of 3.85 lakh shares (52.87% of total volume) and a trailing one-month average of 2.34 lakh shares (48.58%). The one-month delivery volume has increased by 28.99%, and the one-day delivery volume surged 78.36% compared to the five-day average, signalling strong market interest in the stock’s recent price action.
Quality Assessment and Financial Strength
Yatharth Hospital & Trauma Care Services Ltd is classified as an average quality company based on its long-term financial performance. The company boasts an excellent capital structure with negligible debt, reflected in an average debt to EBITDA ratio of 0.23 and a net cash position indicated by a net debt to equity ratio of -0.15. Interest coverage is strong at 36.66 times EBIT to interest, underscoring the company’s ability to service debt comfortably.
Growth metrics are solid, with a five-year sales compound annual growth rate (CAGR) of 30.84% and EBIT growth of 15.55%. The company maintains a healthy average return on capital employed (ROCE) of 19.03%, though return on equity (ROE) is relatively weak at 11.44%. Institutional holdings stand at a moderate 17.26%, and pledged shares constitute 10.73% of the total.
Recent Financial Trends
Short-term financial trends as of December 2025 are positive. Quarterly net sales reached a high of ₹320.47 crores, with profit before depreciation, interest, and taxes (PBDIT) at ₹74.25 crores and profit after tax (PAT) at ₹45.35 crores. Earnings per share (EPS) for the quarter stood at ₹4.71, the highest recorded. However, inventory turnover ratio and debtors turnover ratio were at their lowest levels, at 34.00 times and 2.92 times respectively, indicating areas for operational focus.
Conclusion
The attainment of an all-time high price by Yatharth Hospital & Trauma Care Services Ltd on 7 May 2026 marks a significant milestone in the company’s market trajectory. Supported by strong relative performance against the Sensex and sector peers, robust financial metrics, and a solid balance sheet, the stock’s rise reflects sustained operational and market strength. While valuation multiples suggest a premium, they are consistent with the company’s growth profile and quality indicators. The mildly bullish technical trend and increased delivery volumes further underscore the stock’s positive momentum at this juncture.
